Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
about
Lung cancer in never smokers: clinical epidemiology and environmental risk factorsNicotine: Carcinogenicity and Effects on Response to Cancer Treatment - A ReviewMetabolites of a tobacco-specific lung carcinogen in children exposed to secondhand or thirdhand tobacco smoke in their homesTobacco smoke exposure in nonsmoking hospitality workers before and after a state smoking ban.Sex differences in response to reduced nicotine content cigarettes.Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility studyNicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometryElevated levels of 1-hydroxypyrene and N'-nitrosonornicotine in smokers with head and neck cancer: A matched control study.Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).Exposure to a tobacco-specific lung carcinogen in adolescent versus adult smokersEffect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.Tobacco-specific nitrosamine exposures in smokers and nonsmokers exposed to cigarette or waterpipe tobacco smokeEvaluation of tobacco specific nitrosamines exposure by quantification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human hair of non-smokers.Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation.Reduced nicotine content cigarettes and nicotine patchSmokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine.Nicotine metabolism in three ethnic/racial groups with different risks of lung cancer.A Randomized Controlled Trial of Progressively Reduced Nicotine Content Cigarettes on Smoking Behaviors, Biomarkers of Exposure, and Subjective Ratings.Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers.Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers.Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco.Tobacco carcinogen metabolites and DNA adducts as biomarkers in head and neck cancer: potential screening tools and prognostic indicators.Liquid chromatography-electrospray ionization-tandem mass spectrometry quantitation of urinary [pyridine-D4]4-hydroxy-4-(3-pyridyl)butanoic acid, a biomarker of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolic activation in smokersSmokeless tobacco brand switching: a means to reduce toxicant exposure?A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.
P2860
Q24598433-B04CAAEF-1415-4273-99E6-A9A0381C02C7Q26784043-C4215100-9DEE-444C-ADE6-E03DCBAA19D3Q28389203-9C515221-3B6D-4D71-828E-37109726DCEDQ33807979-F1FBAE65-F892-496A-B093-20EB8DAD0DD5Q33855129-464D110C-ADFA-4E1C-8602-409A97240EAFQ34715402-6EA55AA5-F542-4E35-9AE1-FBED84BC62D1Q34799785-D6D88CEA-CF12-4D3E-A1C6-2CAB9A77591CQ35175672-A66B4CFB-036C-4201-B035-81F3EE674271Q35198490-4204180E-5963-4FDA-9700-49457F3877E6Q35566185-300E0631-827B-4B30-B310-51BCADE60BDBQ35638655-E309BFE0-7EA3-490E-ACC6-BCF4C843C553Q35990500-0CE6B2CB-D125-4343-9908-1DDDC495863BQ36047534-7980D368-D511-48FE-9C27-1F7AA5BFB498Q36047601-46BB34D7-5EF2-4EBA-B3E3-C6F033C8081DQ36471952-59956A36-6879-401D-9FF8-F20BFEAB757CQ36835407-A4047905-1044-4380-8C56-6188E4FCFB6EQ36843611-201D704C-C29A-4679-971E-840F14A875FAQ36927046-640222AA-622B-4AAE-9A91-A2F31B2085C5Q36983085-6FFB0E52-949E-45D6-91DB-50638F2B67B7Q37008114-71CEC006-AC3E-45F9-B01D-6011DA1705D9Q37059838-C224EE01-7D59-48CC-BD44-F514184F4F64Q37149026-1FD998C5-9B1B-4CF3-8BD1-CD9F42D8A97EQ37246043-5BAEA2FA-1D17-4B20-BA9C-68B936F80DE2Q37426846-874EDA46-EAFB-48DC-9810-8B5E00AEA987Q37467562-59940BD6-564C-472C-8A9E-AE58032BCE53Q37880692-F1B763F0-50DD-406E-838F-3340E799F4C2Q39148132-AEB90D1E-F083-48ED-9E24-AB5D732E5542Q41735263-73B3E232-6AA7-40A0-809B-73B124F949DBQ42154700-A6CEEB68-30B9-4DD1-961E-DB877ABE72B4
P2860
Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
@en
type
label
Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
@en
prefLabel
Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
@en
P2093
P1476
Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
@en
P2093
Anne Fristad
Shaomei Han
Stephen S Hecht
Steven G Carmella
Yiying Yang
P304
P433
P577
2003-11-01T00:00:00Z